Description:

NSABP PROTOCOL C-08: FOLLOW-UP FORM Fluorouracil, Leucovorin, and Oxaliplatin With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II or Stage III Colon Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=D7F78B7A-6547-4FB6-E034-0003BA12F5E7

Link:

https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=D7F78B7A-6547-4FB6-E034-0003BA12F5E7

Keywords:
Versions (2) ▾
  1. 8/27/12
  2. 1/9/15
Uploaded on:

January 9, 2015

DOI:
No DOI assigned. To request one please log in.
License:
Creative Commons BY-NC 3.0 Legacy
Model comments:

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for:

Item comments for:

In order to download data models you must be logged in. Please log in or register for free.

Colorectal Cancer NCT00096278 Follow-Up - NSABP PROTOCOL C-08: FOLLOW-UP FORM - 2276708v3.0

Submit every 3 months from date of randomization for the first 2 years; every 6 months for years 3-5; yearly thereafter, and when a protocol event occurs.

Header
Are data amended? (check box if yes, and circle amended items)
Vital Status
Patient's Vital Status
Source of Survival Information (if alive)
Primary Cause of Death (if dead)
Was there evidence of recurrence at the time of death?
Cancer Follow-up Status
Has the patient had a documented clinical assessment for this cancer (since submission of the last follow-up form)?
First Recurrence
Has the patient been diagnosed with first recurrence (since submission of the last follow-up form)? (See "Diagnosis of Colon Cancer Recurrence" in protocol.)
New Primary Cancer Or Mds
Has a new primary cancer or MDS been diagnosed that has not been previously reported?

Similar models